

[ Mon, Nov 27th 2017
] - WOPRAI
[ Mon, Nov 27th 2017
] - WOPRAI
[ Mon, Nov 27th 2017
] - WOPRAI
[ Mon, Nov 27th 2017
] - WOPRAI

[ Wed, Nov 22nd 2017
] - WOPRAI

[ Tue, Nov 21st 2017
] - WOPRAI
[ Tue, Nov 21st 2017
] - WOPRAI
[ Tue, Nov 21st 2017
] - WOPRAI
[ Tue, Nov 21st 2017
] - WOPRAI
[ Tue, Nov 21st 2017
] - WOPRAI
[ Tue, Nov 21st 2017
] - WOPRAI
[ Tue, Nov 21st 2017
] - WOPRAI
[ Tue, Nov 21st 2017
] - WOPRAI
[ Tue, Nov 21st 2017
] - WOPRAI
[ Tue, Nov 21st 2017
] - WOPRAI
Scott Henry Initiated (VKTX) at Strong Buy and Held Target at $5 on, Nov 21st, 2017
Scott Henry of Roth Capital, Initiated "Viking Therapeutics, Inc." (VKTX) at Strong Buy and Held Target at $5 on, Nov 21st, 2017.
Scott has made no other calls on VKTX in the last 4 months.
There is 1 other peer that has a rating on VKTX. Out of the 1 peers that are also analyzing VKTX, 0 agree with Scott's Rating of Hold.
This is the rating of the analyst that currently disagrees with Scott
- Ed Arce of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $7 on, Friday, November 10th, 2017
Contributing Sources